Certain pharmacological effects of a new non-depolarising muscle relaxant, AH 8165 (Glaxo), were studied in 50 patients. The adequate dose for muscle relaxation onset of action, duration of effect and reversibility with cholinesterase agents, were established. Changes in blood pressure, heart rate, intra-ocular pressure, blood gases and acid-base values were measured. In comparison with pancuronium bromide, the onset of action was much more rapid, but the duration of effect was the same. Reversal with anticholinesterase agents was good, and no residual hypoventilation could be detected postoperatively
In a number of animal species dipyrandium chloride (M&B 9105A) was known to be a curare-like rel...
A survey of certain aspects of the literature on neuromuscular blocking agents is given with particu...
Item does not contain fulltextThis study was undertaken to investigate the neuromuscular blocking pr...
During the 16th century, European explorers found that the Indians along the Amazon and Orinoco Rive...
'Onset of action', 'duration of action', 'recovery index' and 'reversibility with anticholinesterase...
Three muscle relaxants, Org 9453, Org 9489 and Org 9487, short-acting in animals, were investigated ...
Forty healthy patients were randomly selected to receive either atracurium 0 6 mg kg ', or summ...
A CAJM article on muscle relaxants in anesthetic practice.It may be stated that the use of the muscl...
RX 72601, a new and potent anticholinesterase, has been evaluated for its ability to reverse the neu...
From results of pharmacological tests on the neuromuscular and autonomic blocking actions of a serie...
An attempt to estimate residual neuromuscular blockade after the administration of anti-depolarizing...
The influence of carbon dioxide on the neuromuscular and haemodynamic effects of AH 8165, a new non-...
The dose-response relationship of Org 9426, its time course of action and the reversibility of the r...
The dose-response relationship of Org 9426, its time course of action and the reversibility of the r...
peer reviewedBackground: Sugammadex rapidly reverses rocuronium-induced neuromuscular block. This st...
In a number of animal species dipyrandium chloride (M&B 9105A) was known to be a curare-like rel...
A survey of certain aspects of the literature on neuromuscular blocking agents is given with particu...
Item does not contain fulltextThis study was undertaken to investigate the neuromuscular blocking pr...
During the 16th century, European explorers found that the Indians along the Amazon and Orinoco Rive...
'Onset of action', 'duration of action', 'recovery index' and 'reversibility with anticholinesterase...
Three muscle relaxants, Org 9453, Org 9489 and Org 9487, short-acting in animals, were investigated ...
Forty healthy patients were randomly selected to receive either atracurium 0 6 mg kg ', or summ...
A CAJM article on muscle relaxants in anesthetic practice.It may be stated that the use of the muscl...
RX 72601, a new and potent anticholinesterase, has been evaluated for its ability to reverse the neu...
From results of pharmacological tests on the neuromuscular and autonomic blocking actions of a serie...
An attempt to estimate residual neuromuscular blockade after the administration of anti-depolarizing...
The influence of carbon dioxide on the neuromuscular and haemodynamic effects of AH 8165, a new non-...
The dose-response relationship of Org 9426, its time course of action and the reversibility of the r...
The dose-response relationship of Org 9426, its time course of action and the reversibility of the r...
peer reviewedBackground: Sugammadex rapidly reverses rocuronium-induced neuromuscular block. This st...
In a number of animal species dipyrandium chloride (M&B 9105A) was known to be a curare-like rel...
A survey of certain aspects of the literature on neuromuscular blocking agents is given with particu...
Item does not contain fulltextThis study was undertaken to investigate the neuromuscular blocking pr...
Add to ORKG